Search Results

73 Results for "enveda biosciences.rss".

Sort By

Press Releases

Enveda Initiates Phase 2 Clinical Trials of ENV-294, a First-in-Class Oral Therapy in Atopic Dermatitis and Asthma

December 10, 2025
·
4 min read
Press Releases

Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory Bowel Disease

December 24, 2025
·
4 min read
Press Releases

Enveda Announces US FDA IND Clearance and First Patient Dosed in Phase 1 Trial of ENV-308, a First-in-Class Oral Therapy for Obesity; Appoints Nadeem Sarwar, Ph.D., MPharm, MPhil, to Lead Metabolic Disease Strategy

December 18, 2025
·
4 min read
Press Releases

Enveda Reports Favorable Phase 1 Safety for Novel Oral Anti-Inflammatory, Launches Phase 1b Trial in Atopic Dermatitis

May 28, 2025
·
3 min read
Press Releases

Enveda Welcomes Jason Kim as Chief Financial Officer

January 10, 2025
·
2 min read
BioMidwest

Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials

Enveda Biosciences, a biotechnology company using AI to translate nature into new medicines, announced a new financing round of $55 million to add to its $119 million combined Series B and B1.

June 14, 2024
·
3 min read
Press Releases

Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board

February 5, 2025
·
4 min read
Press Releases

Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M

February 27, 2025
·
2 min read
Business

Enveda Biosciences Announces Therapeutic Advisory Board Chaired by Nicholas Saccomano, Ph.D.

Enveda Biosciences, a biotechnology company using AI and advanced technologies to translate nature’s chemistry into new medicines, today announced the formation of a Therapeutic Advisory Board (TAB), chaired by Nicholas Saccomano, Ph.D.

January 10, 2024
·
8 min read
Press Releases

Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials

November 13, 2024
·
3 min read